Ovid helps researchers, librarians, clinicians, and other healthcare professionals find important medical information so that they can make critical decisions to improve patient care, enhance ongoing research, and fuel new discoveries. We offer a market-leading medical research platform of premium aggregated content and productivity tools that make it easy to quickly search information and make informed decisions on patient care, quality, and clinical outcomes. Every day, the world's leading medical, academic, and corporate institutions, and thousands of their users rely on Ovid for the most efficient, trusted solution that transforms research into results to help improve patient care.
We partner with more than 150 information producers to provide a selection of current, premium resources aggregated on OvidSP — our flagship research platform. We maintain a commitment to content currency, and support archival resources critical to understanding the historical perspective on medical diagnoses and treatment.
We bring a singular focus to our product offerings—improve research productivity. OvidSP, our industry–leading online search and discovery platform, continues to lead the market with innovative productivity tools and features designed to maximize search precision and efficiency, and simplify and speed analysis and workflow–all in a simple, integrated and easy–to–use system. We provide 24/7/365 Online Access Support, with an award–winning Customer and Technical Support Team based worldwide to assist customers with product setup and implementation, online or on–site training, system customization and personalization to maximize user efficiency and usage.
From its entrepreneurial beginnings in the mid-1980s, Ovid has maintained a steadfast commitment to improving access to medical research through the innovative use of information technology. Formally founded in 1988, Ovid pioneered advancements in compression technology to streamline access to MEDLINE®, the National Library of Medicine's renowned biomedical database. Ovid continued to evolve its research solution in step with the latest online technology while building out its content offerings. Ovid was purchased by Wolters Kluwer in 1998.
The OvidSP platform has advanced to meet the needs of today's users, providing robust results management and personalization tools to increase user productivity and efficiency. Ovid's local–language solution (currently supporting Chinese, French, Spanish, German, Korean, and Japanese) signals the shift in demand for non–English language medical research. Targeted solutions bring an institution's library resources closer to a specific user audience. For instance, OvidMD is ideal for physicians while Nursing@Ovid is designed for nursing professionals. Ovid is a recognized global leader in research information solutions with more than 12,500 medical, academic, and corporate institutions and their users accessing Ovid to inform their work to improve patient care, enhance ongoing research, and fuel new discoveries.
Ovid is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point–of–care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health's customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Lippincott Williams & Wilkins, Ovid®, UpToDate®, Medi–Span®, Facts & Comparisons®, Pharmacy OneSource®, Lexicomp®, and ProVation® Medical.
Ovid is a global organization headquartered in New York, NY with more than 20 offices located all over the world. View a list of additional Ovid offices and locations.
Ovid is part of Wolters Kluwer Health, a global provider of information, business intelligence and point–of–care solutions for the healthcare industry and a Division of Wolters Kluwer, a market–leading global information services company headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Learn more at wolterskluwer.com
Wolters Kluwer employs over 19,300 dedicated employees in more than 40 countries around the world. Our employees are software developers, content editors, and experts in a wide range of professional fields – to name just a few areas of expertise. Innovation is a key driver for our employees and our business – it’s what drives us to do more for our customers.